We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$13.6M
2
TSM icon
TSMC
TSM
+$11.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$11.3M
4
AMAT icon
Applied Materials
AMAT
+$9.44M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$6.99M

Top Sells

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$30.7M
2
TWTR
Twitter, Inc.
TWTR
+$30.3M
3
Y
Alleghany Corp
Y
+$24.9M
4
CTXS
Citrix Systems Inc
CTXS
+$17M
5
ZEN
ZENDESK INC
ZEN
+$15.3M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
1526
Philip Morris
PM
$290B
– –
-28,742
Closed -$2.39M
PNC icon
1527
PNC Financial Services
PNC
$100B
– –
-2,406
Closed -$360K
PNR icon
1528
Pentair
PNR
$10.7B
– –
-10,212
Closed -$415K
PODD icon
1529
Insulet
PODD
$9.91B
– –
-1,661
Closed -$381K
PPG icon
1530
PPG Industries
PPG
$25.7B
– –
-3,231
Closed -$358K
PRGO icon
1531
Perrigo
PRGO
$1.75B
– –
-7,638
Closed -$272K
PRPL icon
1532
Purple Innovation
PRPL
$39.6M
– –
-4,876
Closed -$494K
PSQ icon
1533
ProShares Short QQQ
PSQ
$645M
– –
-2,200
Closed -$164K
PTC icon
1534
PTC
PTC
$16.4B
– –
-21,270
Closed -$2.23M
PTCT icon
1535
PTC Therapeutics
PTCT
$6.23B
– –
-4,609
Closed -$231K
PYXS icon
1536
Pyxis Oncology
PYXS
$243M
– –
-11,052
Closed -$22K
PZZA icon
1537
Papa John's
PZZA
$785M
– –
-6,771
Closed -$474K
QBTS.WS
1538
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
– –
-18,038
Closed -$6K
QGEN icon
1539
Qiagen
QGEN
$9.04B
– –
-5,828
Closed -$255K
QNCX icon
1540
Quince Therapeutics
QNCX
$30M
– –
-51
Closed -$14K
QQQM icon
1541
Invesco NASDAQ 100 ETF
QQQM
$102B
– –
-2,900
Closed -$319K
RARE icon
1542
Ultragenyx Pharmaceutical
RARE
$2.64B
– –
-6,119
Closed -$253K
RDNT icon
1543
RadNet
RDNT
$6.08B
– –
-34,627
Closed -$705K
RF icon
1544
Regions Financial
RF
$26.8B
– –
-172,964
Closed -$3.47M
RMCOW icon
1545
Royalty Management Holding Warrant
RMCOW
$2.08M
– –
-18,484
Closed -$3K
ROP icon
1546
Roper Technologies
ROP
$39.9B
– –
-1,739
Closed -$625K
RRC icon
1547
Range Resources
RRC
$9.41B
– –
-10,856
Closed -$274K
RRR icon
1548
Red Rock Resorts
RRR
$3.58B
– –
-6,306
Closed -$216K
RSG icon
1549
Republic Services
RSG
$65.7B
– –
-3,558
Closed -$484K
SBUX icon
1550
Starbucks
SBUX
$119B
– –
-15,564
Closed -$1.31M
60 61
62
63 64

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.